~~<i id='77E2AFE4CF'><strike id='77E2AFE4CF'><tt id='77E2AFE4CF'><pre id='77E2AFE4CF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：leisure time 2025-10-01 13:58:55 - browse：6

People waiting in line, standing in between red rope. -- first opinion coverage from STAT — Adobe

Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Ohio still needs to do more to protect the right to abortion

focus

hotspot

focus

knowledge

focus

hotspot

AdobeAfewyearsago,Iworkedwithapatientcloseto100yearsold.Shehaddiabetesformostofheradultlife,whichaff

WSS

Surge of respiratory disease in China has likely explanation

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Study suggests Covid rebound is far more common with Paxlovid than without

NYU radiologists take on the challenge of expensive MRI machines

PBM reforms clear House panel

Medicare’s new pay boost for primary care is angering specialists

hotspot

Wikipedia

focus

ChatGPT in medicine: STAT answers readers' burning questions

Today's health inequities arise from racist U.S. history, say experts

Novavax promises a turnaround & Lilly roils the obesity market

Experimental asthma app from Apple and Anthem shows promise

What does generative AI mean for health care? We asked experts

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

The high cost of giving birth even with insurance

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

hotspot

Readout LOUD podcast: A CRISPR milestone, biotech mixology

First transplant of an entire human eye performed

Carbon Health diabetes program, a test of data

Anthos stroke drug appears safer than common blood thinner

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Poor hospice wound care hurts patients and families

focus

knowledge

focus

hotspot